Qool Therapeutics, Inc. — Form D
Qool Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-23. The offering totals $15.2M, of which $6.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-02-23
- Form: D
- Accession: 0001658096-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $15.2M
- Amount sold: $6.7M
- Remaining: $8.5M
- Investors: 65
- Date of first sale: 2017-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281229
Issuer
- Name: Qool Therapeutics, Inc.
- CIK: 0001658096
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1455 ADAMS DRIVE, MENLO PARK, CA, 94025
- Phone: (650) 328-1426
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Beverly Huss | Director | Mountain View, CA |
| Beverly Huss | Executive Officer | Mountain View, CA |
| Fred Moll | Director | Westwood, MA |
| Amir Belson | Director | Fremont, CA |
| Amir Belson | Executive Officer | Fremont, CA |
| Todd Brinton | Director | Santa Clara, CA |
| James Dennis | Director | Menlo Park, CA |
| Ron Dieck | Director | Menlo Park, CA |
Other filings by this issuer (2)
More